Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Harnessing telomerase in cancer therapeuticsJohans Fakhoury, Graeme A M Nimmo, Chantal Autexier
Seminars in Neurology|February 28, 2023
Genetic Testing in Clinical Movement Disorders: A Case-Based ReviewLorraine V Kalia, Graeme A M Nimmo, Tiago A Mestre
American Journal of Medical Genetics. Part A|December 2, 2017
Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiencyGraeme A M Nimmo, Resham Ejaz, Dawn Cordeiro, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 12, 2021
Phenotypic and Genotypic Spectrum of Glucose Transporter-1 Deficiency SyndromeDanielle K Bourque, Dawn Cordeiro, Graeme A M Nimmo, et al.
Internal Medicine Journal|August 27, 2024
The natural history of Gaucher disease type 1 in 31 patients over a median of 15 years: a retrospective studySiavash Piran, Graeme A M Nimmo, Amélie Chaboureau, et al.
American Journal of Medical Genetics. Part A|December 10, 2015
Triplication of 16p12.1p12.3 associated with developmental and growth delay and distinctive facial featuresGraeme A M Nimmo, Andrea Guerin, Ramses Badilla-Porras, et al.
Cancer Letters|December 6, 2008
Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNADelphine T Marie-Egyptienne, Marie Eve Brault, Graeme A M Nimmo, et al.
Human Molecular Genetics|December 23, 2020
De Novo variants in EEF2 cause a neurodevelopmental disorder with benign external hydrocephalusMaria J Nabais Sá, Alexandra N Olson, Grace Yoon, et al.
Neurology. Genetics|May 21, 2021
Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher DiseaseLais M Oliveira, Tara Rastin, Graeme A M Nimmo, et al.
Pageof 2